🔎 Trials Near Me

Akèy › Kansè Vezik ki pa envazif miskilè › Texas › Houston

Etid klinik pou Kansè Vezik ki pa envazif miskilè nan Houston, TX

7 etid pou Kansè Vezik ki pa envazif miskilè ap chèche patisipan nan sit nan ak bò kote Houston (nan yon distans apeprè 30 mil). Louvri yon etid pou wè ki moun ki ka patisipe ak kijan pou kontakte ekip etid la.

Tèks ofisyèl etid la (Anglè)

Ap chèche patisipan pou yon etid? Mete l anwo paj sa a — $99 pou 30 jou →

Efficacy and Safety of TYRA-300 in Participants With FGFR3 Altered Low Grade, Intermediate Risk Non-Muscle Invasive Bladder Cancer

Ap rekriteFaz 2
  • Baylor College of Medicine, Houston
Laj 18 ak plis · Tout sèks · Mizajou Sep 29, 2026 · NCT06995677

Safety and Efficacy Study of Intravesical Instillation of TARA-002 in Adults With High-grade Non-muscle Invasive Bladder Cancer

Ap rekriteFaz 2
  • Houston Metro Urology, Houston
  • Houston Methodist Hospital, Houston
Laj 18 ak plis · Tout sèks · Mizajou Aug 24, 2026 · NCT05951179

FORAGER-1: A Study of Vepugratinib (LY3866288; LOXO-435) in Participants With Cancer With a Change in a Gene Called FGFR3

Ap rekriteFaz 1
  • MD Anderson Cancer Center, Houston
Laj 18 ak plis · Tout sèks · Mizajou Aug 20, 2026 · NCT05614739

LEGEND Study: EG-70 in NMIBC Patients BCG-Unresponsive and High-Risk NMIBC Incompletely Treated With BCG or BCG-Naïve

Ap rekriteFaz 1/2
  • Houston Metro Urology, Houston
  • Houston Methodist Hospital - Department of Urology, Houston
  • University of Texas - MD Anderson Cancer Center, Houston
Laj 18 ak plis · Tout sèks · Mizajou Aug 7, 2026 · NCT04752722

A Study of STM-416 Administered to Patients Undergoing TURBT for Recurrent Bladder Cancer

Ap rekriteFaz 1/2
  • Baylor College of Medicine, Houston
  • Houston Methodist, Houston
Laj 18 ak plis · Tout sèks · Mizajou May 27, 2026 · NCT05710848

Blue Light Cystoscopy With Cysview® Registry

Ap rekriteEtid obsèvasyon
  • Michael E. DeBakey VA Medical Center, Houston
Laj 18 ak plis · Tout sèks · Mizajou Dec 18, 2025 · NCT02660645

Etid Kansè Vezik ki pa envazif miskilè nan lòt vil

Lòt etid nan Houston

Sous ClinicalTrials.gov, done yo ranmase Oct 6, 2026. Chak etid gen kritè li pou li menm; ekip etid la deside ki moun ki ka patisipe.